A related editorial discusses the study, highlighting that although a mechanistic link for this association has been suggested, causation has not been established. The authors suggest prospective randomised clinical trials on de-prescribing could represent a valuable opportunity to test the causal hypothesis between anticholinergic medication use and the diagnosis of Alzheimer disease and related dementias.